BU researchers identify two drugs that delay bone marrow cancer development
Drugs target the dysregulation of the extracellular matrix, an aspect of the disease for which there is currently no treatment
2021-03-22
(Press-News.org) (Boston)--Primary myelofibrosis (PMF), a relatively rare but painful type of bone marrow cancer, disrupts the body's normal production of blood cells by causing extensive scarring in the bone marrow. Regrettably, few treatment options are available, with most of them being palliative in nature. The only curative treatment is a stem cell transplant, for which few patients are eligible.
A new study by researchers at Boston University School of Medicine (BUSM) led by corresponding author Katya Ravid, DSc, has found that the drugs PXS-LOX_1 and PXS-LOX_2 are capable of slowing PMF's disease progression in experimental models.
According to Ravid, professor of medicine and biochemistry at BUSM and professor of biology at Boston University, these drugs are unique because they are able to inhibit their target, a protein called lysyl oxidase, with a combination of specificity and potency not seen in previously tested drugs. These current findings build upon previous discoveries and publications by Ravid and her group, showing what specific proteins in the bone marrow cause the scaring effect observed in PMF.
Three experimental models were used for this study: the first group was normal, while the other two had gene alterations that caused them to develop cancer in their bone marrow. The drug PXS-LOX_1 was given to all three groups. While it caused no significant changes in the normal models, it reduced the severity of the bone marrow cancer symptoms in both altered groups. In a separate experiment, PXS-LOX_2 was given to normal set and one of the genetically altered groups. This test resulted in no change in the normal group, but a reduction in the severity of the cancer symptoms of the altered models.
Ravid, believes these findings are significant because they represent a possible novel avenue of treatment for PMF, since there are currently no available drugs that fight the diseased bone marrow matrix proteins in the way that PXS-LOX_1 and PXS-LOX_2 fight it. "Should these drugs eventually be approved for human use, they could help to slow the progression of the cancer and lessen the painful symptoms of the disease."
The researchers hope that this study will contribute to the development of novel treatment options for primary myelofibrosis. Based on this study, the Australian Biotech Pharmaxis has initiated Phase 1-2 clinical trials in humans.
INFORMATION:
These findings appear online in the journal Archives of Stem Cell and Therapy.
Funding for this study was provided by the National Heart, Lung, and Blood Institute (grant R01HL136363). PXS-LOX_1 and PXS-LOX_2 was provided by Pharmaxis.
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-22
(Boston)--While transgender and gender-diverse individuals have historically been disproportionately susceptible to violence and homicides, the recent rise in visibility of ongoing trans-focused violence has highlighted how the medical-legal community, in general and forensic anthropology, in particular, have largely neglected trans and gender-diverse people.
This is exemplified by a new study that found nearly 30 percent of forensic anthropologists surveyed had participated in a case involving a transgender individual, yet the vast majority (75 percent) were unfamiliar with gender-affirming surgeries.
"Because medical interventions to treat the distress ...
2021-03-22
(Boston)--There are two simultaneously occurring pandemics in the U.S.: Racism and COVID-19. "These mutualistic pandemics have thrown into stark focus the separate and unequal systems through which people access health care," explained corresponding author Emily Cleveland Manchanda, MD, assistant professor of emergency medicine at Boston University School of Medicine.
Cleveland Manchanda and colleagues authored a JAMA Network Open commentary explaining that it is imperative that crisis standards of care (CSC), guidelines designed to ensure the fair allocation of scarce hospital resources across racial and ethnic groups, do not exacerbate racial inequities further. Their commentary is in response to a study also published in JAMA ...
2021-03-22
RESEARCH TRIANGLE PARK, N.C. - Army-funded researchers demonstrated a machine learning approach that corrects quantum information in systems composed of photons, improving the outlook for deploying quantum sensing and quantum communications technologies on the battlefield.
When photons are used as the carriers of quantum information to transmit data, that information is often distorted due to environment fluctuations destroying the fragile quantum states necessary to preserve it.
Researchers from Louisiana State University exploited a type of machine learning to correct ...
2021-03-22
For the study, 209 farmers and 98 environmental scientists were asked how they perceive agricultural biodiversity and its management in Germany and Austria. "The results show that the perceptions of scientists and farmers on biodiversity, ecosystem services and management measures are very different," says Bea Maas, lead author from the University of Vienna. "Especially the diverging perceptions of information sources that are important for agricultural decisions show need for more cross-disciplinary collaboration in sustainable development processes," adds Maas.
The survey integrated ...
2021-03-22
The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph -- one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.
Public participation is critical to the success of any medical research. Yet recruiting volunteers for trials is increasingly challenging. New research from Washington University in St. Louis suggests the widening ideological gap in the U.S. may contribute to these challenges.
Researchers found evidence that Americans approach opportunities to contribute to medical research with either a general aversion or an inclination to participate. This research ...
2021-03-22
While some youth experiment with marijuana but don't go on to long-term use, others develop a problematic pot habit that continues into adulthood. A major new analysis shows that at least a small portion of the risk for developing into an adult marijuana user may be related to inherited behaviors and traits that appear during adolescence.
The journal Addiction published the findings by researchers at Brown University and Emory University.
"Our analysis suggests that some early adolescent behaviors and traits -- like depression, neuroticism and acting out -- can be indicative for cannabis use later in life," says Rohan Palmer, senior author of the paper and assistant professor in Emory's ...
2021-03-22
Politicians and business leaders often make claims about why certain sectors in the economy are shrinking, such as the decline in U.S. manufacturing is due to robotics or trade with China. Such assessments are flawed, as the sectoral composition of the economy is mostly driven by preferences and not by productivity, according to a recent study that models this long-run structural change in the economy. As consumers become richer, they spend more on services such as health and education whose demand is much more income elastic, and less on agriculture and manufactured goods. Until now, productivity has often been considered at least as important, if not more, than preferences, in shaping the sectoral composition of the economy. The results ...
2021-03-22
With the offshore wind industry expanding in the United States and elsewhere, a new study raises questions about how the noise from impact pile driving to install turbine supports can affect feeding behaviors of longfin squid, a commercially and ecologically important cephalopod.
The research, conducted by scientists from the Woods Hole Oceanographic Institution (WHOI) and other institutions, is believed to be the first to demonstrate that anthropogenic noise prompts changes in cephalopod feeding behaviors.
"The whole reason we are doing this study is because we are concerned about how construction from offshore wind farms and the sounds associated with that are going to affect important fisheries species, one ...
2021-03-22
A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance. This is what researchers from Radboud university medical center in Nijmegen, the Netherlands, write in a recent publication. With this they complete a year-long search for the right dosing of an old drug against tuberculosis that appears to be the key drug.
Tuberculosis is a deadly, pertinacious bacterial infectious disease that affects nine million people worldwide each year, mainly in countries in low and middle income countries. For over a million, ...
2021-03-22
Northwestern engineering researchers have demonstrated a new approach to chemical catalysis that results in high propylene yields using less energy. The findings could support more energy-efficient production processes for many plastics.
One of the highest volume chemical products, more than $100 billion worth of propylene is produced each year and used primarily to produce polypropylene for a variety of materials, from injection moldings in car parts to consumer products. Producing propylene is also energy intensive, requiring temperatures around 800 degrees Celsius to convert propane gas to propylene.
One technique, called oxidative dehydrogenation, ...
LAST 30 PRESS RELEASES:
[Press-News.org] BU researchers identify two drugs that delay bone marrow cancer development
Drugs target the dysregulation of the extracellular matrix, an aspect of the disease for which there is currently no treatment
